U.K. regulator mulls £20K cap on ‘systemic stablecoins’ for retail users

ambcryptoPublicado em 2025-11-10Última atualização em 2025-11-11

Key Takeaways 

Why has BoE ditched 2023 stablecoin proposals?

To cater to industry demands and mirror other frameworks in other regions. 

When will these rules be implemented? 

The Bank of England will issue the final rules in H2 2026 after reviewing industry feedback early next year.


In the latest revised plans for the stablecoin guidelines, the Bank of England (BoE) proposed that issuers back their Sterling-based stablecoins through a 60/40 formula. 

The 60% reserve backing would be in interest-bearing short-term government debt or bonds (T-bills), while parking another 40% (non-interest) with the bank. 

In contrast, the U.S. stablecoin law, the GENIUS Act, requires 100% of reserve backing to be in T-bills or cash equivalents, and issuers get all the yield. 

The BoE’s move comes after industry players pushed back against the 2023 proposal, which sought to have the entire 100% reserve assets held by the bank, with no yield. 

At that time, the players argued that the prior proposal was inconsistent with U.S. law and the stablecoin revenue model. 

Reacting to the changes, BoE’s Governor, Andrew Bailey, said, 

“We have listened carefully to and are grateful for the feedback received, which has shaped the proposals we are consulting on today. Following this consultation, we will consider the feedback received before consulting on and finalising our rules in 2026.”

Stablecoin caps remain

Despite the softer stance on reserve assets, the bank will continue to implement the controversial stablecoin caps for individual and business holdings at £20K and £30 million, respectively. 

Worth noting that major financial hubs don’t have similar strict restrictions on stablecoin holdings. But for BoE, it would, 

“Cap potential outflows of bank deposits to systemic stablecoins in aggregate and so limit the potential impact on credit availability.”

The so-called “systematic stablecoins” or payment stablecoins, which are widely used, will fall under the purview of the bank. Think of it as Sterling-based versions of USDT or USDC. 

However, the Financial Conduct Authority (FCA) will monitor “non-systematic stablecoins” currently used for buying or selling crypto assets.

Additionally, issuers will keep the yield they accrue instead of sharing it with holders.

Timeline and implementation

After collecting industry feedback on the latest proposals by February 2026, the regulator will finalize the rules, which are expected to go live in H2 2026. 

UK stablecoinUK stablecoin

Source: BoE

While the U.K.’s stablecoin approach closely mirrors the U.S framework, it appears more conservative to safeguard against any unforeseen systemic risk to the broader financial system. 

Besides pushing for clarity for the same, the U.K. has also softened its stance on retail owning crypto ETNs. 

Share

Leituras Relacionadas

CEO or 'Cult Leader'? Anthropic Faces Backlash Over Its 'Belief'

Anthropic, an AI company nearing trillion-dollar valuation, faces a critical internal challenge: declining morale and a growing rift over its foundational beliefs and leadership. While financial and technical performance remains strong, with Q2 2026 revenue surging over 14x year-over-year and top talent like Google's Justin Gilmer joining, the company's unique culture is under strain. Early employees, who embraced a strong mission-focused culture around AI safety, now coexist with newer hires less aligned with this vision. Anonymous sources report low morale, private channels for airing grievances, and employees torn between staying for valuable equity or leaving due to pressure. CEO Dario Amodei's intense focus on maintaining culture—through rituals like "Dario Vision Quest" meetings and probing "cultural interviews"—faces scrutiny as the company scales. A leaked statement where Amodei suggested Anthropic could one day become "the world's only private company" has fueled external criticism, drawing comparisons to dystopian sci-fi monopolies. The company exhibits contradictions: advocating for AI safety while aggressively pursuing model development and market dominance. It has modified its "Responsible Scaling Policy," faced backlash for attempted AI "sabotage" mechanisms against foreign research, and clashed with the U.S. government over defense contracts. Recent text watermarking for Claude, cited as compliance with EU regulations, has also drawn user criticism. Despite these tensions, Anthropic continues to attract investment, top engineers, and enterprise clients. However, the core "faith" that once unified and distinguished it is now becoming a significant governance and cultural challenge.

marsbitHá 17m

CEO or 'Cult Leader'? Anthropic Faces Backlash Over Its 'Belief'

marsbitHá 17m

Anthropic CEO Denies Rumors, Aims to Transform AI for His Deceased Father and Eradicate Cancer Within 10 Years

Anthropic CEO Dario Amodei has published a rare, lengthy public statement to counter significant criticism from Silicon Valley, as the AI company approaches a potential record-breaking IPO with a reported $2 trillion valuation. The core criticism, amplified by investor Gavin Baker, centers on perceptions that Amodei believes Anthropic should be the world's sole private AI company due to the technology's risks, costs, and power—a view allegedly echoed by NVIDIA's Jensen Huang. Amodei firmly rejects this, arguing it presents a false dichotomy. He defends Anthropic's advocacy for regulation, like California's SB-1047, which he claims imposes costs on frontier AI firms while benefiting smaller competitors, and calls for establishing rules that manage AI risks, constrain corporate power, and preserve open-model development. Shifting to ambition, Amodei outlines a radical vision for AI in biomedicine. He states that within 5-10 years, AI could cure most human diseases, a mission deeply personal due to his father's death from hepatitis C just years before a cure became available. Amodei asserts that public trust in AI will be earned not by promises or benchmarks, but by tangible results—AI actually saving lives. He confirms Anthropic is significantly increasing its biology and medical AI investments, with preliminary results expected within months. This narrative reframing comes ahead of Anthropic's anticipated IPO, positioning the company not just as an OpenAI competitor, but as one aiming to solve humanity's fundamental challenges.

marsbitHá 17m

Anthropic CEO Denies Rumors, Aims to Transform AI for His Deceased Father and Eradicate Cancer Within 10 Years

marsbitHá 17m

Trading

Spot
活动图片